The molecular-topology method that identified the therapeutic potential of dutasteride in ALS was based on a discriminant analysis using three computational models that considered the general activity and specific activity in ALS clinical trials and TDP-43 molecular binding due to its strong relationship with the pathogenesis of the disease. The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.